Mobile
Dosage Comparison Charts

Articles
[2] New "intermediate" strength fentanyl patches will raise questions about appropriate dosing (7/15)
[3] Trulicity (TRUE-lih-sih-tee, dulaglutide) is another GLP-1 agonist for type 2 diabetes (12/14)
[4] options to prevent chemo-induced nausea and vomiting (12/14)
[5] more interest in "abuse-deterrent" opioid formulations (5/14)
[6] skyrocketing costs of GENERIC drugs (3/14)
[7] Does it ever make sense to dose extended-release metformin or basal insulin twice daily (11/12)
[8] how to safely switch opioid analgesics (8/12)
-- Strategies for Switching Between Opioid Analgesics
-- CHART
[9] new debate about which anticoagulant is best to prevent strokes in atrial fib patients (3/12)
-- Does Pradaxa (dabigatran) Increase Heart Attack Risk?
-- CHART
[0] more generic ARBs in 2012 (3/12)
-- New Generic ARBs
-- CHART
[-] you'll see more interest in using chlorthalidone instead of hydrochlorothiazide for hypertension (2/12)
-- Hydrochlorothiazide vs Chlorthalidone for Hypertension
-- CHART
[-] more emphasis on preventing bleeding due to anticoagulants in elderly patients (1/12)
-- Oral Anticoagulants: Maximizing Safety
-- CHART
[-] shortages of Adderall (amphetamine salts) and some methylphenidate products (12/11)
-- When and How to Use Stimulants for ADHD
-- CHART
[-] You'll see a big shift in statin use when atorvastatin (Lipitor) goes generic at the end of November (11/11)
-- Shift in Statin Use with Generic Atorvastatin
-- CHART
[-] two new opioid formulations, Oxecta and Lazanda (10/11)
-- New Opioid Formulations: Oxecta and Lazanda
-- CHART